Top Markets
Coin of the day
Septerna Inc Septerna Inc

Septerna Inc

SEPN
Classement en actions #6851
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops... Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves’ disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women’s health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
Prix de l'action
$40.61
Dernière synchronisation: 2026-08-27
Capitalisation boursière
$1.83B
Changement (1 jour)
0.89%
Changement (1 an)
230.70%
Pays
US
Échange Septerna Inc (SEPN)

Catégorie

Historique du prix de l'action pour Septerna Inc (SEPN)
Prix de clôture le plus élevé : $42.39 le 2026-08-01

Prix de clôture le plus bas : $21.08 le 2024-10-01
Historique du prix de l'action de Septerna Inc de 2024 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -1.18%
2025 12.66%
2024 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$548.36 39.87%
US
$1.06K 50.29%
NL
$121.12 -12.78%
AU
$140.81 475.44%
US
$765.25 7.74%
CH